Cargando…
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome
Bronchiolitis Obliterans Syndrome seriously reduces long-term survival of lung transplanted patients. Up to now there is no effective therapy once BOS is established. Nanomedicine introduces the possibility to administer drugs locally into lungs increasing drug accumulation in alveola reducing side...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693282/ https://www.ncbi.nlm.nih.gov/pubmed/33244143 http://dx.doi.org/10.1038/s41598-020-77828-y |